# International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

> **NCT00593229** · — · TERMINATED · sponsor: **Northwell Health** · enrollment: 6 (actual)

## Conditions studied

- Thrombotic Microangiopathy
- Hemolytic Uremic Syndrome
- Thrombotic Thrombocytopenic Purpura

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00593229
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2011-10
- **Final completion:** —
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** study stopped at this site, as investigator left the institution
- **Last updated:** 2013-06-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593229, "International Registry and Biorepository for TMA(Thrombotic Microangiopathy)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00593229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*